Latest news
Loading news…
Vivo Infusion
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Lakewood, Colorado, United States Founded 2022 501-1000 employees For Profit
Vivo Infusion Centers operates multispecialty ambulatory infusion clinics.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
5
Monthly Visits
Available in Pro Contacts
87
Patents
0
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 20
- Patents granted
- 0
- Trademarks
- 1
- IT spend
- $265K
Company Info
- Founded
- 2022
- Employees
- 501-1000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Sub-organizations
- 1
- News articles
- 15
- HQ
- Lakewood, Colorado, United States
- Region
- Greater Denver Area, Western US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 5
- Trend (30d)
- 3.9
- Trend (90d)
- 2.9
- Last leadership hire
- Oct 15, 2024
Acquisitions by Vivo Infusion
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Vivo Infusion
CEO
87
professional contacts at Vivo Infusion
Contact execs at Vivo Infusion →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Vivo Infusion
Loading news…
FAQs about Vivo Infusion
People who checked this page also checked these
Sectors Vivo Infusion invests & acquires in
Browse the full Acquirezy directory.